EPO squeezes hESC patenting in line with court ruling, but impact could be limited
This article was originally published in Scrip
Executive Summary
The European Patent Office has declared that a stem cell invention derived using a method that necessarily involves the destruction of a human embryo cannot be patented. In doing so, it has followed last year's ruling from the Court of Justice of the EU, even though as a non-EU body it was not bound to do so.